Secor Capital Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Secor Capital Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-86,896	Closed	-$1.46M	–	628
2018 Q3	$1.46M	Buy	+86,896	New	+$1.88M	0.16%	197
2018 Q2	–	Sell	-27,720	Closed	-$446K	–	661
2018 Q1	$446K	Buy	+27,720	New	+$549K	0.04%	386
2017 Q4	–	Sell	-74,774	Closed	-$1.05M	–	612
2017 Q3	$1.05M	Buy	+74,774	New	+$676K	0.1%	266
2017 Q1	–	Sell	-115,953	Closed	-$514K	–	622
2016 Q4	$514K	Buy	+115,953	New	+$486K	0.06%	343
2016 Q3	–	Sell	-218,519	Closed	-$1.44M	–	693
2016 Q2	$1.44M	Buy	+218,519	New	+$1.54M	0.18%	183
2016 Q1	–	Sell	-56,842	Closed	-$343K	–	782
2015 Q4	$343K	Buy	+56,842	New	+$325K	0.1%	339

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Secor Capital Advisors's SPPI Position: Q4 2018 in Review

Secor Capital Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2018, closing a stake of 86,896 shares — an estimated $1.46M sold.

Secor Capital Advisors first reported a position in SPPI in Q4 2015 and held it in 6 quarters. The position peaked at $1.46M in Q3 2018. 176 funds tracked by Wall St. Rank hold SPPI as of Q4 2018.

Secor Capital Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Secor Capital Advisors sold 86,896 Spectrum Pharmaceuticals Inc shares in Q4 2018, an estimated $1.46M.
Secor Capital Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q4 2015 and held it in 6 quarters.
Secor Capital Advisors's Spectrum Pharmaceuticals Inc position peaked at $1.46M in Q3 2018.
176 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2018.

Based on Secor Capital Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.